Scientists at Harvard's Wyss Institute for Biologically Inspired Engineering have unveiled their newest tool for drug testing, dubbed bone marrow-on-a-chip, the first device of its kind that mimics the structure, functions and cellular make-up of ... BioScreening, 2 months ago
2 images for "harvard bone marrow initiative"
The global capital of entrepreneurship last week was….Buffalo, N.Y. As part of a billion-dollar initiative to kickstart the western New York economy, Buffalo hosted the biggest pitchcontest ever: $5 million, doled out to 11 startups last Thursday, ...Forbes.com, 2 weeks ago
I n an advance against cancer metastasis, scientists at the Harvard-affiliated Dana-Farber Cancer Institute have shown that a specially developed compound can impede multiple myeloma in mice from spreading to the bones. The findings, published in ...Harvard University Gazette, 2 months ago New test developed at Dana-Farber/Brigham and Women's Cancer Center EurekAlert!, 1 week ago Novel compound prevents metastasis of multiple myeloma in mouse studies EurekAlert!, 2 months ago
This morning, the Fred Hutchinson Cancer Research Center in Seattle, a hotbed for the development of new treatments that harness the immune system against cancer, is announcing that it has hired former Merck cancer research boss Gary Gilliland as ...Forbes.com, 5 days ago Fred Hutchinson Cancer Research Center Recruits As Its New President And Director BioSpace, 5 days ago Fred Hutch announces Dr. Gary Gilliland as new president and director Fred Hutchinson Cancer Research Center, 5 days ago Fred Hutch recruits D. Gary Gilliland as its new president and director Tamar Securities, 5 days ago
Image Tools WASHINGTON—Stating that progress in oncology is at a critical juncture, a multidisciplinary working group released a comprehensive issue brief at a conference here intended to improve the value of cancer care and ensure that it is ...Oncology Times, 1 week ago
BY MEERI KIM, PHD A new retrospective cohort study has for the first time defined the clinical course of light-chain smoldering multiple myeloma—i.e., the disease stage preceding light-chain multiple myeloma. A subset of patients with ...Oncology Times, 1 week ago Debating Upfront Transplant in Multiple Myeloma Oncology Times, 1 month ago ONLINE FIRST: Upfront Transplant in Multiple Myeloma? Clinicians' Choice Split Oncology Times, 1 month ago
Becker's Hospital Review is pleased to recognize 100 physician leaders of hospitals and health systems for 2014, based on leaders' healthcare experience, accolades and commitment to quality care. Note: This list is not an endorsement of included ...Beckers Hospital Review, 3 weeks ago
Summary HART's bioreactor and scaffold product has been used to regenerate the human trachea using stem cells. Around 10 human tracheae have been successfully implanted, saving patients' lives. The company has a proven management in the medical ...Seeking Alpha, 3 weeks ago
It may seem intuitive that, in stem cell transplantation, two units of cord blood may bestow significantly better outcomes than one unit of cord blood. But at least in children, that may not be the case: the outcomes were similar after both. ...Medscape, 3 weeks ago
Operator Good afternoon, and welcome to the Sangamo BioSciences teleconference to discuss Third Quarter 2014 Financial Results. This call is being recorded. I will now pass you over to your coordinator of this event, Dr. Elizabeth Wolffe, Vice ...Seeking Alpha, 1 month ago
on your WebpageAdd Widget >Get your members hooked!